Update on the association between Helicobacter pylori infection and asthma in terms of microbiota and immunity

H. pylori is a gram-negative bacterium that is usually acquired in childhood and can persistently colonize the gastric mucosa of humans, affecting approximately half of the world’s population.

In recent years, the prevalence of H. pylori infection has steadily reduced while the risk of allergic diseases has steadily climbed.

As a result, epidemiological research indicates a strong negative association between the two.

Moreover, numerous experimental studies have demonstrated that eradicating H. pylori increases the risk of allergic diseases.

Hence, it is hypothesized that H. pylori infection may act as a safeguard against allergic diseases.

The hygiene hypothesis, alterations in gut microbiota, the development of tolerogenic dendritic cells, and helper T cells could all be involved in H. pylori’s ability to protect against asthma.

Furthermore, Studies on mice models have indicated that H. pylori and its extracts are crucial in the management of asthma.

We reviewed the in-depth studies on the most recent developments in the relationship between H. pylori infection and allergic diseases, and we discussed potential mechanisms of the infection’s protective effect on asthma in terms of microbiota and immunity.

We also investigated the prospect of the application of H. pylori and its related components in asthma, so as to provide a new perspective for the prevention or treatment of allergic diseases.